Yves Fradet

5PUBLICATIONS
139CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersPacific Peoples diet and nutritionCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 13, 2025
The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

Takafumi N Yamaguchi, Kathleen E Houlahan, Helen Zhu

|Oct 30, 2024
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.

Aude Fléchon, Rafael Morales-Barrera, Thomas Powles

|Mar 29, 2023
Effects of Concentrated Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Quality of Life after Radical Prostatectomy: A Phase II Randomized Placebo-Controlled Trial (RCT-EPA).

Hanane Moussa, Karine Robitaille, Jean-François Pelletier

|Mar 05, 2022
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.

Joaquim Bellmunt, Ronald de Wit, Yves Fradet

|Aug 16, 2020
Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.

Andrée-Anne Grosset, Frédérick Dallaire, Tien Nguyen

Pageof 1

Frequent Collaborators

2 joint publications

Razvan Cristescu

2 joint publications

Louis Lacombe

2 joint publications

Blanca Homet Moreno

2 joint publications

Thomas Powles